- Roger Pebody | 05 July 2013
One of the anxieties in relation to ‘treatment as
prevention’ is that it may discourage people with HIV from using condoms and
other prevention methods. However, a meta-analysis has found no increase ...
- Liz Highleyman | 05 July 2013
The effectiveness of initial antiretroviral treatment
has improved markedly over the years, but many people still do not achieve full
HIV suppression and a majority end up going off their initial regimen ...
- Roger Pebody | 04 July 2013
An HIV prevention intervention in which young people who had
tested negative for sexually transmitted infections were given lottery tickets
and had the possibility of winning a cash prize reduced the number ...
- Roger Pebody | 04 July 2013
Countries such as China, Cambodia and Vietnam have made
strong commitments to curbing their HIV epidemics through the expansion of HIV
testing and antiretroviral treatment, but numerous challenges remain, according
to speakers at ...
- Liz Highleyman | 04 July 2013
The
once-daily HIV integrase inhibitor dolutegravir demonstrated better efficacy
than twice-daily raltegravir for previously treated people with HIV, with fewer
study withdrawals due to virological failure and less emergent drug resistance,
researchers reported on ...
- Liz Highleyman | 04 July 2013
Lowering the dosage of efavirenz (Sustiva or Stocrin) from 600 to 400mg in an antiretroviral regimen did not
compromise efficacy, a finding that has the potential to substantially reduce
treatment cost in ...
- Liz Highleyman | 04 July 2013
A second-line regimen consisting of a protease
inhibitor (PI) plus two nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs)
led to good outcomes for people with HIV in Africa after initial regimen
failure, according to data ...
- Gus Cairns | 04 July 2013
The 7th
International AIDS Society Conference on HIV
Pathogenesis, Treatment and Prevention
heard two late-breaker presentations providing new data about two
studies of pre-exposure prophylaxis (PrEP) in injecting drug users
and in men who have ...
- Roger Pebody | 04 July 2013
HIV-negative women who wish to become pregnant with their
male HIV-positive partner can be reassured that pre-exposure prophylaxis (PrEP)
appears to be a safe option in terms of maternal and infant outcomes, ...
- Gus Cairns | 03 July 2013
The
results of a pioneering HIV prevention trial comparing the effects of
mobile HIV testing, community mobilisation, and enhanced support for
people with HIV versus standard voluntary counselling and testing
(VCT) was announced at ...
- Keith Alcorn | 03 July 2013
Two people with HIV who received stem cell transplants for
the treatment of lymphoma are now controlling HIV replication without
medication in the early weeks of treatment interruption, following the
discovery that both ...
- Lesley Odendal | 03 July 2013
Peer-mediated
HIV counselling resulted in the highest uptake of HIV counselling and testing
(HCT) among male most-at-risk populations (M-MARPS), according to a longitudinal analysis of three
testing strategies conducted in three states in ...
- Gus Cairns | 03 July 2013
The 7th International AIDS Society Conference on HIV
Pathogenesis, Treatment and Prevention (IAS 2013)
in Kuala Lumpur featured a special
two-day symposium on
progress towards a cure for HIV and also featured a number ...
- Keith Alcorn | 03 July 2013
People with HIV who start treatment with CD4 counts above
500, after the first phase of primary infection is over, are much more likely
to experience substantial reductions in the reservoir of ...
- Roger Pebody | 03 July 2013
A randomised controlled trial in Kenya has found that home
visits immediately after a woman’s appointment at the antenatal clinic
increased the numbers of male partners who were tested for HIV, according ...
- Keith Alcorn | 02 July 2013
Another case of prolonged control of HIV
replication after stopping treatment was reported on Tuesday at the 7th
International AIDS Society conference (IAS 2013), indicating that cases of post-treatment
control of HIV are ...
- Liz Highleyman | 02 July 2013
People taking hepatitis C treatment who reduced their dose of ribavirin due to
side-effects nevertheless had a high likelihood of achieving sustained virological response
when treated with an all-oral regimen containing three ...
- Liz Highleyman | 02 July 2013
International drug policy must shift from
prohibition to public health in order to reduce harms to individuals and
societies, including fueling the spread of HIV, hepatitis and tuberculosis,
experts from a range of ...
- Lesley Odendal | 02 July 2013
Believing that drugs and supplies are generally available at the local health facility and experiencing more than three symptoms of depression after HIV diagnosis were found to be associated with ...
- Michael Carter | 02 July 2013
There is a high
incidence of hepatitis C virus (HCV) reinfection among gay men living with HIV in London, results of
a study published in the online edition of AIDS
show. The research ...